Skip to main content
Equibles

BARCLAYS PLC

Position in INMB — Inmune Bio, Inc.

CIK 312069 LONDON, X0
Back to INMB Full portfolio

Position in INMB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$23,402
+$2,333 QoQ
Shares Held
14,358
-23.0% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 83 holders
Holding Since
Jun 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. INMB ranks #306 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in INMB

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $23,402 14,358
2026-03-31 $21,069 18,646
2025-12-31 $49,948 32,018
2025-09-30 $62,112 30,006
2025-06-30 $87,746 37,986
2025-03-31 $154,966 19,842
2024-12-31 $149,528 32,019
2024-09-30 $156,547 29,044
2024-06-30 $36,497 4,138
2021-03-31 $19,803 1,667
2020-12-31 $48,439 2,813
2020-09-30 $29,002 2,813
2020-06-30 $5 1